Found: 11
Select item for more details and to access through your institution.
Design and characterization of protective pan-ebolavirus and pan-filovirus bispecific antibodies.
- Published in:
- PLoS Pathogens, 2024, v. 20, n. 4, p. 1, doi. 10.1371/journal.ppat.1012134
- By:
- Publication type:
- Article
Combination therapy protects macaques against advanced Marburg virus disease.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22132-0
- By:
- Publication type:
- Article
A shared structural solution for neutralizing ebolaviruses.
- Published in:
- Nature Structural & Molecular Biology, 2011, v. 18, n. 12, p. 1424, doi. 10.1038/nsmb.2150
- By:
- Publication type:
- Article
Analytical Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection.
- Published in:
- Journal of Infectious Diseases, 2016, v. 214, p. S210, doi. 10.1093/infdis/jiw293
- By:
- Publication type:
- Article
Development of Prototype Filovirus Recombinant Antigen Immunoassays.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Reversion of Ebolavirus Disease from a Single Intramuscular Injection of a Pan-Ebolavirus Immunotherapeutic.
- Published in:
- Pathogens, 2022, v. 11, n. 6, p. 655, doi. 10.3390/pathogens11060655
- By:
- Publication type:
- Article
The Ebola Virus Interferon Antagonist VP24 Directly Binds STAT1 and Has a Novel, Pyramidal Fold.
- Published in:
- PLoS Pathogens, 2012, v. 8, n. 2, p. 1, doi. 10.1371/journal.ppat.1002550
- By:
- Publication type:
- Article
The Ebola Virus VP30-NP Interaction Is a Regulator of Viral RNA Synthesis.
- Published in:
- PLoS Pathogens, 2016, v. 12, n. 10, p. 1, doi. 10.1371/journal.ppat.1005937
- By:
- Publication type:
- Article
Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primates.
- Published in:
- Science Translational Medicine, 2024, v. 16, n. 741, p. 1, doi. 10.1126/scitranslmed.adl2055
- By:
- Publication type:
- Article
Structural and mechanistic basis of neutralization by a pan-hantavirus protective antibody.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 700, p. 1, doi. 10.1126/scitranslmed.adg1855
- By:
- Publication type:
- Article
Human antibody recognizing a quaternary epitope in the Puumala virus glycoprotein provides broad protection against orthohantaviruses.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 636, p. 1, doi. 10.1126/scitranslmed.abl5399
- By:
- Publication type:
- Article